Literature DB >> 18368133

Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Hiroki Inui1, Kyu-Seon Oh, Carine Nadem, Takahiro Ueda, Sikandar G Khan, Ahmet Metin, Engin Gozukara, Steffen Emmert, Hanoch Slor, David B Busch, Carl C Baker, John J DiGiovanna, Deborah Tamura, Cornelia S Seitz, Alexei Gratchev, Wen Hao Wu, Kee Yang Chung, Hye Jin Chung, Esther Azizi, Roger Woodgate, Thomas D Schneider, Kenneth H Kraemer.   

Abstract

Xeroderma pigmentosum-variant (XP-V) patients have sun sensitivity and increased skin cancer risk. Their cells have normal nucleotide excision repair, but have defects in the POLH gene encoding an error-prone polymerase, DNA polymerase eta (pol eta). To survey the molecular basis of XP-V worldwide, we measured pol eta protein in skin fibroblasts from putative XP-V patients (aged 8-66 years) from 10 families in North America, Turkey, Israel, Germany, and Korea. Pol eta was undetectable in cells from patients in eight families, whereas two showed faint bands. DNA sequencing identified 10 different POLH mutations. There were two splicing, one nonsense, five frameshift (3 deletion and 2 insertion), and two missense mutations. Nine of these mutations involved the catalytic domain. Although affected siblings had similar clinical features, the relation between the clinical features and the mutations was not clear. POLH mRNA levels were normal or reduced by 50% in three cell strains with undetectable levels of pol eta protein, indicating that nonsense-mediated message decay was limited. We found a wide spectrum of mutations in the POLH gene among XP-V patients in different countries, suggesting that many of these mutations arose independently.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368133      PMCID: PMC2562952          DOI: 10.1038/jid.2008.48

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  73 in total

Review 1.  Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.

Authors:  H van Steeg; K H Kraemer
Journal:  Mol Med Today       Date:  1999-02

2.  Isolation and characterization of novel plasmid-encoded umuC mutants.

Authors:  R Woodgate; M Singh; O I Kulaeva; E G Frank; A S Levine; W H Koch
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

3.  Pigmented Xerodermoid: first report of a family.

Authors:  H Hofmann; E G Jung; U W Schnyder
Journal:  Bull Cancer       Date:  1978       Impact factor: 1.276

4.  Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene.

Authors:  E M Taylor; B C Broughton; E Botta; M Stefanini; A Sarasin; N G Jaspers; H Fawcett; S A Harcourt; C F Arlett; A R Lehmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

5.  A simple method for diagnosing xeroderma pigmentosum variant.

Authors:  T Itoh; T Ono; M Yamaizumi
Journal:  J Invest Dermatol       Date:  1996-09       Impact factor: 8.551

6.  Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts.

Authors:  Y C Wang; V M Maher; D L Mitchell; J J McCormick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  Ultraviolet hypermutability of a shuttle vector propagated in xeroderma pigmentosum variant cells.

Authors:  H L Waters; S Seetharam; M M Seidman; K H Kraemer
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

8.  Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases.

Authors:  K H Kraemer; M M Lee; J Scotto
Journal:  Arch Dermatol       Date:  1987-02

9.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.

Authors:  K H Kraemer; M M Lee; A D Andrews; W C Lambert
Journal:  Arch Dermatol       Date:  1994-08

10.  A simple and rapid method for evaluating the survival of xeroderma pigmentosum lymphoid lines after irradiation with ultraviolet light.

Authors:  A N Moshell; R E Tarone; S A Newfield; A D Andrews; J H Robbins
Journal:  In Vitro       Date:  1981-04
View more
  37 in total

1.  A novel POLH gene mutation in a xeroderma pigmentosum-V Tunisian patient: phenotype-genotype correlation.

Authors:  Mariem Ben Rekaya; Olfa Messaoud; Amel Mebazaa; Olfa Riahi; Hela Azaiez; Rim Kefi; Mohamed Zghal; Samir Boubaker; Ahlem Amouri; Amel Ben Osman-Dhahri; Sonia Abdelhak; Mourad Mokni
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

2.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 3.  Clinical utility gene card for: Xeroderma pigmentosum.

Authors:  Steffen Schubert; Janin Lehmann; Limor Kalfon; Hanoch Slor; Tzipora C Falik-Zaccai; Steffen Emmert
Journal:  Eur J Hum Genet       Date:  2013-10-09       Impact factor: 4.246

4.  Roles of Residues Arg-61 and Gln-38 of Human DNA Polymerase η in Bypass of Deoxyguanosine and 7,8-Dihydro-8-oxo-2'-deoxyguanosine.

Authors:  Yan Su; Amritraj Patra; Joel M Harp; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

5.  Interferon regulatory factor 1 transactivates expression of human DNA polymerase η in response to carcinogen N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  Hongyan Qi; Huifang Zhu; Meng Lou; Yanfeng Fan; Hong Liu; Jing Shen; Zhongjie Li; Xue Lv; Jianzhen Shan; Lijun Zhu; Y Eugene Chin; Jimin Shao
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

6.  Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.

Authors:  Nils H Nicolay; Rebecca Carter; Stephanie B Hatch; Niklas Schultz; Remko Prevo; W Gillies McKenna; Thomas Helleday; Ricky A Sharma
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

Review 7.  Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.

Authors:  Deborah Tamura; John J DiGiovanna; Sikandar G Khan; Kenneth H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2014-02-19       Impact factor: 3.135

8.  Structure and mechanism of human DNA polymerase eta.

Authors:  Christian Biertümpfel; Ye Zhao; Yuji Kondo; Santiago Ramón-Maiques; Mark Gregory; Jae Young Lee; Chikahide Masutani; Alan R Lehmann; Fumio Hanaoka; Wei Yang
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

9.  Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication.

Authors:  Laurie Rey; Julia M Sidorova; Nadine Puget; François Boudsocq; Denis S F Biard; Raymond J Monnat; Christophe Cazaux; Jean-Sébastien Hoffmann
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

10.  Mechanism of Ribonucleotide Incorporation by Human DNA Polymerase η.

Authors:  Yan Su; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.